1. Home
  2. LFVN

as of 01-02-2026 3:29pm EST

$6.01
$0.15
-2.44%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Founded: N/A Country:
United States
United States
Employees: N/A City: LEHI
Market Cap: 145.2M IPO Year: N/A
Target Price: $35.00 AVG Volume (30 days): 192.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
2.98%
Dividend Payout Frequency: Quarterly
EPS: 0.78 EPS Growth: 143.91
52 Week Low/High: $5.69 - $27.38 Next Earning Date: 02-04-2026
Revenue: $228,877,000 Revenue Growth: 16.77%
Revenue Growth (this year): 1.54% Revenue Growth (next year): 7.00%

AI-Powered LFVN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 68.42%
68.42%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)

Buy
LFVN Dec 15, 2025

Avg Cost/Share

$6.54

Shares

805

Total Value

$5,264.62

Owned After

131,553

SEC Form 4

Sell
LFVN Nov 7, 2025

Avg Cost/Share

$7.13

Shares

36,000

Total Value

$249,582.50

Owned After

35,389

Latest Lifevantage Corporation (Delaware) News

LFVN Breaking Stock News: Dive into LFVN Ticker-Specific Updates for Smart Investing

All LFVN News

Share on Social Networks: